Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-PDGF: Epoetin Beta for Renal Function Post-Transplant
NCT00815867Phase 3Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Oct 2007
- Primary completion
- Apr 2009
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of epoetin beta in delayed graft function (DGF) (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Glomerular Filtration Rate at 30 days. Started Oct 2007; status: completed.
02
Drugs
epoetin beta
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT00815867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00815867.